ACM
CLLS

Adalta Capital Management’s Cellectis CLLS Stock Holding History

Adalta Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23,075
Closed -$651K – 74
2018
Q3 		$651K Buy
23,075
+1,175
+5% +$33.8K 0.46% 48
2018
Q2 		$620K Buy
+21,900
New +$652K 0.44% 47

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adalta Capital Management's CLLS Position: Q4 2018 in Review

Adalta Capital Management sold out of Cellectis (CLLS) in Q4 2018, closing a stake of 23,075 shares — an estimated $651K sold.

Adalta Capital Management first reported a position in CLLS in Q2 2018 and held it in 2 quarters. The position peaked at $651K in Q3 2018. 65 funds tracked by Wall St. Rank hold CLLS as of Q4 2018.

  • Adalta Capital Management reported no remaining Cellectis position as of Q4 2018 after selling out during the quarter.
  • Adalta Capital Management sold 23,075 Cellectis shares in Q4 2018, an estimated $651K.
  • Adalta Capital Management first reported a position in Cellectis in Q2 2018 and held it in 2 quarters.
  • Adalta Capital Management's Cellectis position peaked at $651K in Q3 2018.
  • 65 funds tracked by Wall St. Rank held Cellectis as of Q4 2018.

Based on Adalta Capital Management's 13F filing for Q4 2018, filed 15 Feb 2019.